Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)
Abroad (travel likely)Recruiting
Conditions
Stroke · Moyamoya Disease · Cerebral Amyloid Angiopathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Michigan, Italy
Contact: Study coordinator (Matilde Leonardi, MD) · matilde.leonardi@istituto-besta.it · +39 02 2394 2511